Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C

Blood Cancer J. 2016 Mar 11;6(3):e402. doi: 10.1038/bcj.2016.16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Disease Progression
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Humans
  • Lymphoma, Mantle-Cell / diagnosis*
  • Lymphoma, Mantle-Cell / drug therapy
  • Lymphoma, Mantle-Cell / etiology*
  • Lymphoma, Mantle-Cell / pathology
  • Male
  • Middle Aged
  • Sofosbuvir / adverse effects*
  • Sofosbuvir / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Sofosbuvir